(Q33491073)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

main subject

metastatic breast cancer

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

L Repetto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

L Miglietta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

G Gardin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

C Lanfranco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

C Naso

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

S Giudici

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

A Venturino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

E Campora

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

F Testore

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

language of work or name

English

0 references

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

133-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7949211%20AND%20SRC:MED&resulttype=core&format=json

Epirubicin treatment of advanced breast carcinoma with the weekly low-dose regimen

29 October 2019

cites work

1 reference

12 December 2020

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma

1 reference

12 December 2020

Refractory metastatic breast cancer: salvage therapy with fluorouracil and high-dose continuous infusion leucovorin calcium

1 reference

12 December 2020

Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity

1 reference

12 December 2020

Severe life-threatening toxicities observed in study using leucovorin with 5-fluorouracil

1 reference

12 December 2020

Continuous 5-fluorouracil infusion in refractory carcinoma of the breast

1 reference

12 December 2020

Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer

1 reference

12 December 2020

Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on Survival

1 reference

12 December 2020

Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B

1 reference

12 December 2020

Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group study

1 reference

12 December 2020

A comparison of mitoxantrone and doxorubicin in breast cancer.

1 reference

12 December 2020

Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer

1 reference

12 December 2020

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

1 reference

12 December 2020

Dihydroxyanthracenedione: A Promising New Drug in the Treatment of Metastatic Breast Cancer

1 reference

12 December 2020

Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer

1 reference

12 December 2020

Phase II study of mitoxantrone in patients with metastatic breast carcinoma: a Southeastern Cancer Study Group project

1 reference

12 December 2020

Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer

1 reference

12 December 2020

5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study

1 reference

12 December 2020

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

12 December 2020

An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patients

1 reference

12 December 2020

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

1 reference

12 December 2020

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1 reference

12 December 2020

Salvage therapy for metastatic disease

1 reference

12 December 2020